Literature DB >> 29450849

Impaired arterial responsiveness in untreated gout patients compared with healthy non-gout controls: association with serum urate and C-reactive protein.

Svetlana Krasnokutsky1,2,3, Aaron Garza Romero1,2,3, Daisy Bang1,2,3, Virginia C Pike1,2,3, Binita Shah3,4,5, Talia F Igel1,2,3, Irina Dektiarev3,4,5, Yu Guo3,5,6, Judy Zhong3,5,6, Stuart D Katz3,5, Michael H Pillinger7,8,9,10.   

Abstract

To determine whether arterial responsiveness is impaired among patients with gout, and whether arterial responsiveness inversely correlates with serum urate and inflammatory measures. This is a cross-sectional study of untreated gout subjects (n = 34) and non-gout healthy controls (n = 64). High-resolution dynamic ultrasound-measured flow-mediated dilation (FMD) and nitroglycerin-mediated dilation (NMD) assessed endothelium-dependent and endothelium-independent arterial responsiveness respectively. Serum urate (sUA) and high-sensitivity C-reactive protein (hsCRP) were measured in the gout group, and correlated with FMD and NMD responses. Both FMD (2.20 ± 0.53 vs 3.56 ± 0.31, p = 0.021) and NMD (16.69 ± 1.54 vs 24.51 ± 0.90, p = 0.00002) were impaired in the gout versus control group. Stratification for individual comorbidities suggested that no single risk factor accounted for impaired FMD/NMD in the gout subjects. However, the degree of association between gout and FMD, but not NMD impairment, was dampened after multivariable adjustment (FMD unadjusted beta = - 1.36 (SE 0.58), p = 0.02; adjusted beta = - 1.16 (SE 0.78), p = 0.14 and NMD unadjusted beta = - 7.68 (SE 1.78), p < 0.0001; adjusted beta = - 5.33 (SE 2.46), p = 0.03). Within the gout group, there was an inverse correlation between FMD and sUA (R = - 0.5, p = 0.003), and between FMD and hsCRP (R = - 0.42, p = 0.017), but not between NMD and sUA or hsCRP. Compared with healthy controls, subjects with gout have reduced arterial function. Individual comorbidities are insufficient to account for differences between gout and control groups, but multiple comorbidities may collectively contribute to impairment in endothelium-dependent arterial responsiveness. Endothelial impairment is also related to sUA and hsCRP, markers of gout severity and inflammation respectively. Studies to determine whether gout therapy may improve arterial responsiveness are warranted.

Entities:  

Keywords:  Arterial function; Endothelium; Flow-mediated dilation; Gout; Hyperuricemia; Inflammation

Mesh:

Substances:

Year:  2018        PMID: 29450849     DOI: 10.1007/s10067-018-4029-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  49 in total

1.  C-reactive protein: linking inflammation to cardiovascular complications.

Authors:  E T Yeh; H V Anderson; V Pasceri; J T Willerson
Journal:  Circulation       Date:  2001-08-28       Impact factor: 29.690

Review 2.  Inflammation, atherosclerosis, and coronary artery disease.

Authors:  Göran K Hansson
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis.

Authors:  You-Jin Choi; Yujin Yoon; Kang-Yo Lee; Tran Thi Hien; Keon Wook Kang; Kyong-Cheol Kim; Jeewoo Lee; Moo-Yeol Lee; Seung Mi Lee; Duk-Hee Kang; Byung-Hoon Lee
Journal:  FASEB J       Date:  2014-03-20       Impact factor: 5.191

Review 5.  The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial.

Authors:  Thura T Abd; Danny J Eapen; Ambareesh Bajpai; Abhinav Goyal; Allen Dollar; Laurence Sperling
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

6.  Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.

Authors:  Duk-Hee Kang; Sung-Kwang Park; In-Kyu Lee; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 10.121

7.  Determinants of vascular function in patients with chronic gout.

Authors:  Robert D Brook; Srilakshmi Yalavarthi; James D Myles; Shokoufeh Khalatbari; Rita Hench; Susan Lustig; Wendy Marder; Adam Neidert; Mariana J Kaplan
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-22       Impact factor: 3.738

8.  Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.

Authors:  Wolfram Doehner; Nina Schoene; Mathias Rauchhaus; Francisco Leyva-Leon; Darrell V Pavitt; David A Reaveley; Gerhard Schuler; Andrew J S Coats; Stefan D Anker; Rainer Hambrecht
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

9.  Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.

Authors:  T P Mikołajczyk; G Osmenda; B Batko; G Wilk; M Krezelok; D Skiba; T Sliwa; J R Pryjma; T J Guzik
Journal:  Lupus       Date:  2015-08-06       Impact factor: 2.911

Review 10.  Uric acid: A marker of increased cardiovascular risk.

Authors:  Ana C M Gagliardi; Marcio H Miname; Raul D Santos
Journal:  Atherosclerosis       Date:  2008-05-21       Impact factor: 5.162

View more
  4 in total

1.  Assessment of aortic stiffness in patients with ankylosing spondylitis using cardiovascular magnetic resonance.

Authors:  P Stefan Biesbroek; Sjoerd C Heslinga; Peter M van de Ven; Mike J L Peters; Raquel P Amier; Thelma C Konings; Christopher D Maroules; Colby Ayers; Parag H Joshi; Irene E van der Horst-Bruinsma; Vokko P van Halm; Albert C van Rossum; Michael T Nurmohamed; Robin Nijveldt
Journal:  Clin Rheumatol       Date:  2018-05-12       Impact factor: 2.980

Review 2.  COVID-19 and the Heart and Vasculature: Novel Approaches to Reduce Virus-Induced Inflammation in Patients With Cardiovascular Disease.

Authors:  Bernard S Kadosh; Michael S Garshick; Juan Gaztanaga; Kathryn J Moore; Jonathan D Newman; Michael Pillinger; Ravichandran Ramasamy; Harmony R Reynolds; Binita Shah; Judith Hochman; Glenn I Fishman; Stuart D Katz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-07-20       Impact factor: 8.311

Review 3.  Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout.

Authors:  Romy Hansildaar; Daisy Vedder; Milad Baniaamam; Anne-Kathrin Tausche; Martijn Gerritsen; Michael T Nurmohamed
Journal:  Lancet Rheumatol       Date:  2020-09-01

4.  Initiating guideline-concordant gout treatment improves arterial endothelial function and reduces intercritical inflammation: a prospective observational study.

Authors:  Michael Toprover; Binita Shah; Cheongeun Oh; Talia F Igel; Aaron Garza Romero; Virginia C Pike; Fatmira Curovic; Daisy Bang; Deana Lazaro; Svetlana Krasnokutsky; Stuart D Katz; Michael H Pillinger
Journal:  Arthritis Res Ther       Date:  2020-07-11       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.